NZ212338A - Insulin formulations, processes for their preparation and their use - Google Patents

Insulin formulations, processes for their preparation and their use

Info

Publication number
NZ212338A
NZ212338A NZ212338A NZ21233885A NZ212338A NZ 212338 A NZ212338 A NZ 212338A NZ 212338 A NZ212338 A NZ 212338A NZ 21233885 A NZ21233885 A NZ 21233885A NZ 212338 A NZ212338 A NZ 212338A
Authority
NZ
New Zealand
Prior art keywords
plunger pipe
plate
damper
sealing plate
pipe
Prior art date
Application number
NZ212338A
Inventor
U Grau
G Ross
D Hiller
H P Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NZ212338A publication Critical patent/NZ212338A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • External Artificial Organs (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

1. Pulsation damper (10) for elastically disposed objects (26), including a damper housing which is at least partially filled with 3 viscose damping medium (12) and which is open at the top relative to its installation position ; a hollow plunger pipe (17) which is open at the bottom relative to its installation position and continuously conically formed and which can be moved up and down into the damper medium (12) ; a top plate (16), linked with the plunger pipe (17), for receiving the object (26), in which respect the plunger pipe (17) is connected with the top plate (16) by its smaller diameter (28), and its larger diameter (29) is emersed into the damper medium (12), characterised in that the interior of the plunger pipe (17) is divided into two chambers by a sealing plate (22) ; that a buffer plate (24) including passages (33) is disposed in the larger diameter (29) at the bottom of the plunger pipe (17) which plate carries a plurality of interior pipes (21) which extend into the plunger pipe (17), the upper ends of the interior pipes (21) being at a distance (35) from the sealing plate (22), and the plunger pipe (17) has a plurality of peripheral bores (19) in the casing surface below the sealing plate (22).
NZ212338A 1984-06-09 1985-06-07 Insulin formulations, processes for their preparation and their use NZ212338A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3421613 1984-06-09
DE3421615 1984-06-09
DE19843443877 DE3443877A1 (en) 1984-06-09 1984-12-01 Insulin preparations, process for their preparation, and their use

Publications (1)

Publication Number Publication Date
NZ212338A true NZ212338A (en) 1989-02-24

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ212338A NZ212338A (en) 1984-06-09 1985-06-07 Insulin formulations, processes for their preparation and their use

Country Status (16)

Country Link
EP (1) EP0166971B1 (en)
AT (1) ATE50502T1 (en)
AU (1) AU575951B2 (en)
CA (1) CA1258427A (en)
DE (1) DE3576120D1 (en)
DK (1) DK162255C (en)
ES (1) ES8605679A1 (en)
FI (1) FI80596C (en)
GR (1) GR851393B (en)
HU (1) HU200102B (en)
IE (1) IE57998B1 (en)
IL (1) IL75448A (en)
NO (1) NO164277C (en)
NZ (1) NZ212338A (en)
PH (1) PH24118A (en)
PT (1) PT80620B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179479C (en) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Process for the preparation of an intravaginal pharmaceutical preparation
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
DE10227232A1 (en) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Sour insulin preparations with improved stability
DK2349324T3 (en) 2008-10-17 2017-12-11 Sanofi Aventis Deutschland COMBINATION OF AN INSULIN AND A GLP-1 AGONIST
JP5973918B2 (en) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Pharmaceutical composition comprising a GLP-1 agonist and methionine
KR101836070B1 (en) 2009-11-13 2018-03-09 사노피-아벤티스 도이칠란트 게엠베하 Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
PT2611458T (en) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (en) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
EP3517122A1 (en) 2013-04-03 2019-07-31 Sanofi Treatment of diabetes mellitus by long-acting formulations of insulins
CN107206058A (en) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 Insulin glargine/lixisenatide fixed ratio preparaton
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (en) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Method of treating diabetes mellitus
IL66610A (en) * 1981-08-27 1985-11-29 Lilly Co Eli Human proinsulin pharmaceutical formulations
FI78616C (en) * 1982-02-05 1989-09-11 Novo Industri As Process for preparing an infused stabilized insulin solution having an elevated zinc content
WO1985005036A1 (en) * 1984-04-30 1985-11-21 The Trustees Of Columbia University In The City Of Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
EP0166971B1 (en) 1990-02-28
CA1258427A (en) 1989-08-15
NO164277C (en) 1990-09-19
IE851431L (en) 1985-12-09
AU575951B2 (en) 1988-08-11
ES8605679A1 (en) 1986-01-16
ES543972A0 (en) 1986-01-16
HUT37893A (en) 1986-03-28
IE57998B1 (en) 1993-06-02
GR851393B (en) 1985-11-25
EP0166971A1 (en) 1986-01-08
NO852314L (en) 1985-12-10
ATE50502T1 (en) 1990-03-15
DK162255C (en) 1992-03-16
HU200102B (en) 1990-04-28
FI80596C (en) 1990-07-10
FI852273A0 (en) 1985-06-06
DK254585D0 (en) 1985-06-06
DE3576120D1 (en) 1990-04-05
IL75448A (en) 1989-07-31
NO164277B (en) 1990-06-11
FI852273L (en) 1985-12-10
DK162255B (en) 1991-10-07
PT80620A (en) 1985-07-01
FI80596B (en) 1990-03-30
PT80620B (en) 1987-10-20
PH24118A (en) 1990-03-05
AU4342485A (en) 1985-12-12
IL75448A0 (en) 1985-10-31
DK254585A (en) 1985-12-10

Similar Documents

Publication Publication Date Title
NZ212338A (en) Insulin formulations, processes for their preparation and their use
JPS646543A (en) Vibration isolating device
FI871937A (en) ANORDERING FOR ANAEROBIC RENGTHENING AV AVFALLSVATTEN.
ATE46892T1 (en) CONTINUOUS FILLING DEVICE.
DE3866619D1 (en) BIOGAS REACTOR.
DE69010781D1 (en) Device for chest drainage.
ATE195337T1 (en) POSITIONABLE PETRI DISH
DE3664298D1 (en) Energy absorbers
JPS5519989A (en) Liquid ring pump
GR3006386T3 (en)
DE3564858D1 (en) Arrangement with a sealed evacuated hollow body
MY101782A (en) Method for removing a volatile material from a liquid and equipment for the working of this method
ES257901U (en) Tomamuestras head for blood sedimentation speed meter. (Machine-translation by Google Translate, not legally binding)
DE3273037D1 (en) Horizontal chamber coke oven
JPS5676793A (en) Lubricator
JPS56116938A (en) Buffer
FR2424147A2 (en) Suspended seat for wheeled or tracked vehicle - has vertical oscillations damped by hydraulic and pneumatic chambers, with fluid transfer controlled by lever-operated distributor
JPS6254885U (en)
SE8400668L (en) VIBRATOR
UA39943C2 (en) ENERGY COMPENSATOR